rfhg_44129.1

Basic information about the TSS

---

TSS ID: rfhg_44129.1 TSS ID(Version3): hg_36179.1 hg_36177.1 hg_36178.1 hg_36176.1 Species: human Chr: chr3		Start: 40309679 End: 40309809 Strand: +
Source datasets	FANTOM5|EPD|DRA000914|PRJNA548673|PRJNA615891|PRJNA401781 |DRA013844|PRJNA597322|PRJDB5282|PRJNA4843412
Protocol	CAGE|TSS_database|ReCappable-seq|SLIC_CAGE|oligo_capping |TIF-seq2|RAMPAGE|STRIPE-seq|C1CAGE|NETCAGE
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3416884,EH38E2194231)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000232905.4:0 ENST00000462088.1:0 AK223448:0 BC006996:0 AF077052:0 AF263452:0 AK311922:0 GeneID: 10289 HGNC/MGI_ID: HGNC:30792 UniProt_ID: Q53F41 Q6FG85 Nearer transcript ids and distances: ENST00000488260.1:17 AF064607:61 KJ892992:127 LF208859:132 MA444436:132 CR542223:133 view more...

Gene_name: eukaryotic translation initiation factor 1B Gene_symbol: EIF1B Gene_synonyms: GC20 Gene_source: HGNC:30792

TATA-Box annotation

---

Distance to TSS:	37
Nearest PromoterID:	NM_005875
Entrez ID:	10289
Nearest Unigene:	Hs.315230
Nearest Refseq:	NM_005875
Nearest Ensembl:	ENSG00000114784
Gene Name:	eukaryotic translation initiation factor 1B
Gene Alias:	GC20
Gene Type:	protein-coding
CpG%:	0.107692
GC%:	0.656489
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF1B p2@EIF1B p3@EIF1B p4@EIF1B p5@EIF1B
Sample		p1@EIF1B	p2@EIF1B	p3@EIF1B	p4@EIF1B	p5@EIF1B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	146.49	11.30	11.30	21.23	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	131.10	9.91	8.09	21.65	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	143.91	14.08	8.49	18.13	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	186.50	12.06	14.55	18.92	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	193.25	11.25	9.45	27.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	161.25	11.05	8.92	23.64	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	140.32	14.60	11.77	25.49	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	152.84	9.69	9.45	24.71	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	149.82	7.05	6.63	26.29	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	286.34	16.23	6.38	27.24	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	278.11	11.32	5.66	25.87	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	270.36	10.98	7.32	28.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	52.39	24.98	7.25	20.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.41	20.00	9.77	13.98	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	48.74	25.47	10.54	16.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	62.37	25.15	10.56	16.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	48.49	25.99	8.95	17.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	39.65	24.47	8.01	14.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	45.85	20.79	17.59	15.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	55.36	26.93	12.19	18.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	46.64	22.32	12.30	11.23	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	55.41	25.89	12.08	16.40	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	54.29	24.56	11.76	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	64.55	24.99	14.56	20.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	75.33	30.18	14.71	25.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	54.76	20.89	12.34	10.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	71.98	45.06	13.74	23.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	70.25	21.22	14.85	17.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	67.52	26.81	12.44	15.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	73.29	29.32	14.66	18.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	92.74	29.31	14.03	18.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	98.28	34.00	20.71	21.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	76.81	31.23	18.78	17.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	78.35	32.33	22.60	19.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	111.82	30.48	22.44	17.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	109.80	31.23	24.34	21.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	115.88	35.15	22.69	21.87	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	107.39	29.01	24.58	18.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	115.06	35.38	26.20	18.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	93.62	27.61	22.57	14.40	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	114.10	25.64	21.17	20.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	70.27	31.04	25.18	18.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	112.62	32.48	25.10	18.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	117.48	28.50	25.87	16.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	102.59	26.10	21.48	14.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	75.38	25.36	19.77	15.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	110.60	30.95	22.31	15.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	69.15	24.14	18.48	13.11	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	62.72	28.25	22.74	15.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	66.52	20.42	16.98	11.32	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	59.44	26.64	21.32	10.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	50.26	24.02	24.02	12.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.36	16.32	17.74	12.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.78	19.88	18.23	9.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	25.17	23.49	10.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.52	26.18	23.88	12.86	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	50.24	31.11	29.49	12.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	46.57	24.73	20.55	11.88	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	38.03	42.12	30.49	18.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	45.12	18.33	19.04	11.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	32.53	19.63	17.95	11.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	29.46	24.68	19.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	32.28	31.26	34.32	10.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	49.39	33.79	38.99	11.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.72	17.04	32.66	8.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	31.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	27.30	19.01	16.09	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	23.31	18.35	17.85	6.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	23.46	20.17	8.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.45	37.76	26.50	20.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.88	29.70	23.20	15.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.88	27.21	17.73	13.76	0.00
Adipocyte - breast, donor1	11376-118A8	31.04	20.59	27.08	7.29	0.16
Adipocyte - breast, donor2	11327-117E4	27.59	16.52	17.65	5.61	0.16
Adipocyte - omental, donor1	11473-119C6	55.85	21.37	26.46	12.98	0.25
Adipocyte - omental, donor2	11474-119C7	38.87	30.65	23.17	8.22	0.00
Adipocyte - omental, donor3	11475-119C8	42.87	28.80	32.49	12.39	0.33
Adipocyte - perirenal, donor1	11476-119C9	45.94	28.71	21.69	8.93	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	8.80	8.80	8.80	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	28.90	16.26	15.36	9.03	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.84	20.85	12.16	9.56	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	35.20	18.77	21.90	5.87	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	38.35	13.64	18.02	5.92	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	21.74	10.87	22.86	4.46	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	33.51	13.52	15.87	8.23	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	40.70	16.57	11.90	6.27	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	30.66	13.56	22.59	6.13	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	31.46	9.60	17.06	6.40	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	45.63	12.80	12.80	9.46	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	27.45	13.31	12.48	5.41	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	33.15	9.80	16.07	5.53	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	24.87	9.82	8.18	0.98	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	26.79	7.61	10.96	6.70	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	53.26	10.61	7.29	4.64	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	37.65	17.21	6.81	6.45	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	10.78	2.40	10.78	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	37.42	29.32	15.65	9.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	31.80	18.41	16.73	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	24.24	30.82	15.00	10.07	0.21
Anulus Pulposus Cell, donor1	11248-116E6	26.55	27.58	17.85	9.84	0.00
Anulus Pulposus Cell, donor2	11463-119B5	25.47	32.08	19.10	7.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.26	18.87	33.25	6.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	28.22	22.14	30.39	6.08	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	21.40	19.26	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.09	22.72	31.69	6.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	22.76	22.76	6.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.76	11.22	25.74	7.92	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.42	15.59	26.97	6.17	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	17.96	28.64	5.34	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	22.57	15.44	21.97	7.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	13.56	25.23	9.04	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	15.96	24.67	5.08	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	12.54	22.57	7.52	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.70	17.13	22.90	5.11	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	25.93	24.57	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.74	23.37	25.94	9.80	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	18.22	23.57	5.89	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	21.35	15.30	22.11	8.12	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.65	15.24	20.58	5.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	30.24	16.58	26.34	5.85	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.23	19.24	21.23	6.30	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	12.01	16.81	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	14.16	14.16	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	22.99	22.13	23.16	6.18	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	8.39	33.56	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	20.87	16.02	33.01	4.37	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.83	19.35	22.77	8.73	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	12.11	23.02	3.63	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	17.10	22.23	5.13	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.45	23.73	19.03	7.70	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.29	17.81	17.29	6.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	15.01	24.40	7.98	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.79	16.40	19.94	9.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	14.27	24.26	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	12.28	28.66	8.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	28.30	18.67	27.40	8.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	26.14	33.26	4.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	18.82	31.02	7.12	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	27.76	19.61	24.20	6.62	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.15	15.25	17.79	8.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	18.12	29.78	5.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	20.53	18.63	26.04	7.83	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	35.09	22.91	26.97	8.70	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	23.62	13.23	25.51	7.56	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.43	18.65	21.36	6.95	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	18.53	34.75	6.95	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	14.79	29.58	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	44.38	19.73	28.73	9.22	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	51.74	17.45	34.29	12.63	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	23.33	41.55	8.02	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.23	17.70	27.36	8.28	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	22.95	38.25	15.30	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	90.00	29.24	49.32	12.20	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	43.15	24.36	35.71	8.46	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.92	21.73	27.85	10.10	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	31.55	19.12	40.15	9.56	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	34.15	24.39	26.17	10.87	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	32.04	33.57	39.67	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	31.57	16.06	39.33	7.20	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	26.21	18.27	29.66	5.56	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	41.80	19.99	28.35	9.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	80.44	36.48	22.97	14.25	0.12
Astrocyte - cerebellum, donor2	11580-120F5	37.66	33.38	13.52	8.04	0.00
Astrocyte - cerebellum, donor3	11661-122F5	99.00	24.33	13.84	13.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	78.78	25.45	10.11	10.11	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.05	24.59	14.72	11.49	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	52.06	17.15	11.93	8.80	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	34.18	35.32	10.32	10.90	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	34.95	35.96	10.90	9.40	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	31.41	28.68	11.27	9.67	0.00
Basophils, donor1	12241-129G9	61.98	26.41	18.31	13.08	0.00
Basophils, donor2	12242-129H1	95.61	35.72	46.54	17.68	1.80
Basophils, donor3	12243-129H2	75.70	23.23	19.55	9.26	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	21.56	11.00	3.02	3.67	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	21.49	14.63	4.11	6.40	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	0.00	7.17	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	13.81	13.81	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	23.29	12.48	7.49	5.82	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	47.90	31.32	11.51	6.68	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	34.91	9.72	5.58	8.28	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	65.13	23.19	9.48	15.15	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	118.32	33.31	12.81	21.89	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	73.23	45.73	44.45	12.47	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	72.39	51.71	20.68	0.00
CD14+ Monocytes, donor1	11224-116B9	370.82	47.90	68.19	18.03	8.45
CD14+ Monocytes, donor2	11305-117B9	559.03	55.12	60.32	38.60	8.17
CD14+ Monocytes, donor3	11381-118B4	447.20	47.86	58.62	23.71	7.03
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	39.06	50.95	54.06	7.36	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	52.31	41.70	49.28	14.78	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.60	47.34	46.68	11.83	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	63.60	46.83	38.74	12.72	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	77.85	29.57	41.34	11.77	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	83.86	45.96	46.90	11.13	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	105.13	42.02	55.24	14.06	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	134.97	34.23	44.16	13.25	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	156.20	49.83	72.64	17.11	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	182.29	57.37	72.45	18.21	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	167.37	47.54	58.58	12.82	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	226.99	59.20	95.97	21.76	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	416.98	66.02	108.17	23.88	2.34
CD14+ monocytes - treated with Candida, donor2	11878-125C6	453.58	62.31	91.35	17.95	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	318.39	54.36	96.51	33.28	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	75.56	40.61	42.69	8.78	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	85.61	30.53	43.70	10.38	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	79.12	39.35	64.75	11.66	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	480.91	74.36	126.29	32.72	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	351.29	47.28	76.91	27.37	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	431.22	50.19	109.12	28.37	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	122.93	54.60	68.59	15.87	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	127.53	46.93	55.48	11.69	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	147.29	49.66	67.75	17.25	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1012.80	94.24	209.98	72.93	3.86
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1355.52	75.03	206.43	75.03	2.47
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1227.55	85.11	250.51	69.32	5.26
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	167.40	51.27	58.07	12.73	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	166.51	47.57	39.40	11.89	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	189.68	51.52	77.17	16.81	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	755.50	79.03	154.38	45.04	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	732.02	52.39	130.04	48.91	3.25
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	720.10	78.65	231.30	48.02	3.02
CD14+CD16+ Monocytes, donor1	11789-124B7	39.02	28.77	12.64	10.68	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	56.82	31.18	19.63	8.08	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	41.81	24.48	18.85	11.26	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	47.65	47.03	21.33	7.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	45.93	39.12	27.77	9.43	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	58.19	34.56	19.62	10.70	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	45.42	32.66	17.35	12.50	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	52.92	28.10	17.13	11.42	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	55.37	26.11	15.79	10.53	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	109.74	22.36	26.42	44.71	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	128.14	34.58	16.27	39.32	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	148.09	30.03	22.78	31.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	113.54	19.72	21.32	36.78	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	142.59	23.05	15.01	40.74	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	125.65	26.67	17.55	38.61	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	125.50	29.02	13.33	21.96	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	127.87	21.09	14.50	39.55	0.00
CD19+ B Cells, donor1	11544-120B5	667.38	33.70	26.30	57.53	4.93
CD19+ B Cells, donor2	11624-122B4	560.03	23.21	34.82	49.33	1.45
CD19+ B Cells, donor3	11705-123B4	659.30	26.76	27.26	55.53	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	344.26	28.28	13.33	45.25	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	332.78	25.97	17.58	43.94	0.00
CD34+ Progenitors, donor1	11545-120B6	106.43	37.15	39.16	10.04	0.00
CD34+ Progenitors, donor2	11625-122B5	311.24	61.80	65.73	43.26	6.18
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.59	32.69	38.70	8.64	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	55.92	43.29	42.62	12.18	0.23
CD4+ T Cells, donor1	11225-116C1	238.16	51.42	44.28	23.21	2.14
CD4+ T Cells, donor2	11306-117C1	213.10	45.93	33.07	23.27	4.29
CD4+ T Cells, donor3	11382-118B5	122.00	38.73	43.00	19.82	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	29.86	30.12	25.78	8.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.64	43.12	28.30	13.70	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.44	44.84	34.21	17.25	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	141.28	52.15	55.94	30.82	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	179.09	47.76	47.06	37.93	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	161.51	36.26	16.48	36.26	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.21	34.97	27.89	6.94	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.86	46.77	29.15	10.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.24	37.08	30.95	7.90	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.45	54.24	45.28	17.04	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	97.13	56.60	44.02	23.06	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	77.44	40.92	38.72	25.08	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.35	30.36	30.78	8.01	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.69	39.06	32.00	6.44	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	37.09	30.07	7.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	113.40	46.50	38.34	20.40	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	154.35	41.80	38.59	23.05	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	125.53	43.04	35.86	21.52	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	22.62	39.31	29.11	7.60	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	23.61	34.23	35.09	9.31	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.17	40.14	39.93	8.20	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	60.17	33.37	46.52	14.16	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	67.59	39.86	46.79	10.40	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	74.96	31.81	49.68	19.18	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	65.32	37.61	51.47	21.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	42.47	51.70	48.93	18.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	44.67	65.60	18.15	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.12	50.95	55.39	24.09	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	55.95	56.69	55.21	20.61	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	43.12	46.20	27.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	52.29	43.69	45.12	16.47	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	30.47	56.78	72.02	12.46	0.00
CD8+ T Cells, donor1	11226-116C2	104.44	40.27	50.42	13.10	2.29
CD8+ T Cells, donor2	11307-117C2	85.97	39.04	55.56	14.64	1.88
CD8+ T Cells, donor3	11383-118B6	183.56	55.30	54.03	20.70	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.71	15.37	13.76	3.21	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.37	16.30	11.02	5.75	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.80	22.98	11.22	3.01	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	22.22	21.92	19.81	6.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.80	17.76	12.48	3.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	29.79	20.01	13.19	5.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.68	26.51	25.86	4.78	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	25.00	27.37	19.48	4.47	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.87	21.34	20.64	5.39	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	33.81	27.17	14.49	6.04	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.54	21.50	13.94	7.84	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	31.97	24.51	15.72	4.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	55.59	27.14	29.77	13.13	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.47	27.33	26.41	8.65	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	76.08	41.77	33.56	13.43	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	41.78	14.77	15.49	5.76	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	37.40	21.58	12.66	4.60	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.00	24.28	16.26	5.42	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.30	17.75	24.08	6.65	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.68	25.84	24.30	4.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	31.42	27.57	21.80	3.85	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.54	27.16	20.27	3.06	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	37.05	18.13	17.73	5.12	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	28.74	32.53	19.67	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	103.58	43.36	36.94	24.09	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	100.02	55.95	19.58	7.69	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	80.14	24.04	18.03	10.02	1.00
Cardiac Myocyte, donor1	11525-119I4	78.59	29.24	38.38	16.45	0.00
Cardiac Myocyte, donor2	11605-120I3	51.88	16.80	28.66	8.89	0.49
Cardiac Myocyte, donor3	11686-122I3	55.14	15.68	20.84	7.58	0.11
Chondrocyte - de diff, donor1	11261-116G1	75.23	54.77	46.80	16.99	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.90	16.35	19.90	6.04	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.75	24.80	21.73	5.35	0.23
Chondrocyte - re diff, donor2	11339-117F7	12.53	22.38	23.28	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	30.73	20.22	21.03	10.51	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	46.59	27.43	16.53	9.30	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	34.20	17.53	15.60	5.34	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	32.12	22.74	13.81	6.81	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	143.79	29.44	20.72	16.78	0.28
Corneal Epithelial Cells, donor1	11526-119I5	24.37	11.86	4.17	4.61	0.00
Corneal Epithelial Cells, donor2	11606-120I4	30.72	12.51	4.55	4.55	0.00
Corneal Epithelial Cells, donor3	11687-122I4	27.10	14.06	5.11	6.90	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	17.34	19.15	37.31	2.64	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.93	20.50	39.11	4.10	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	13.80	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	13.07	16.74	25.27	1.51	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	57.40	54.32	63.55	6.15	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	37.87	41.13	48.97	13.71	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	39.20	58.56	66.78	11.61	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	15.01	16.18	17.51	2.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	7.63	15.26	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	22.91	11.88	15.27	3.68	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	16.12	11.01	12.19	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	10.47	9.89	13.38	2.04	0.29
Endothelial Cells - Artery, donor2	11341-117F9	23.53	14.12	15.06	3.53	0.47
Endothelial Cells - Artery, donor3	11413-118E9	16.30	14.90	19.46	2.98	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.39	16.62	21.28	3.32	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.78	11.26	17.34	2.13	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.26	14.94	17.76	5.07	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	25.26	13.97	14.26	4.16	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	35.93	11.45	11.98	5.73	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	18.72	12.05	7.09	3.69	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	34.41	36.41	9.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	9.43	16.77	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.69	24.10	27.71	4.60	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.11	19.99	19.99	5.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.85	19.42	12.58	5.50	0.12
Endothelial Cells - Vein, donor1	11267-116G7	7.96	9.10	17.06	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	9.78	8.38	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	12.87	13.97	3.30	0.00
Eosinophils, donor1	12244-129H3	30.49	15.25	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	123.77	42.91	36.31	18.15	0.00
Eosinophils, donor3	12246-129H5	99.87	24.97	46.37	17.83	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.84	9.28	2.44	1.95	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	52.00	10.40	12.48	6.24	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	48.81	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	68.97	27.09	36.95	15.60	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	27.04	11.06	12.48	6.02	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.49	34.02	26.11	14.41	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	21.22	16.98	18.07	5.34	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	49.13	15.97	21.97	4.50	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	31.75	15.71	21.20	7.07	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	32.41	22.40	19.23	7.64	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.57	21.59	14.95	5.65	0.33
Fibroblast - Cardiac, donor1	11268-116G8	33.57	17.24	14.97	3.18	0.00
Fibroblast - Cardiac, donor2	11345-117G4	19.71	9.85	7.58	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.98	10.72	8.20	4.10	0.00
Fibroblast - Cardiac, donor4	11452-119A3	39.71	17.58	13.94	7.58	0.00
Fibroblast - Cardiac, donor5	11456-119A7	43.53	33.00	31.47	9.01	0.38
Fibroblast - Cardiac, donor6	11460-119B2	27.14	26.83	27.74	6.67	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	58.69	29.21	25.32	15.81	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	32.36	18.55	17.26	4.31	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	70.31	14.65	5.86	16.11	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	330.51	56.51	27.91	29.98	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	48.34	33.58	19.84	11.19	0.34
Fibroblast - Dermal, donor1	11269-116G9	23.01	14.09	13.15	6.57	0.23
Fibroblast - Dermal, donor2	11346-117G5	25.94	9.91	16.51	5.19	0.00
Fibroblast - Dermal, donor3	11418-118F5	21.40	18.13	20.31	5.20	0.00
Fibroblast - Dermal, donor4	11450-119A1	60.03	42.62	23.85	13.00	0.00
Fibroblast - Dermal, donor5	11454-119A5	54.43	32.80	23.38	9.07	0.35
Fibroblast - Dermal, donor6	11458-119A9	42.23	34.43	19.33	8.77	0.16
Fibroblast - Gingival, donor1	11237-116D4	28.11	24.36	19.37	5.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	20.44	29.34	6.03	0.26
Fibroblast - Gingival, donor2	11318-117D4	32.55	24.78	17.79	7.12	0.40
Fibroblast - Gingival, donor3	11394-118C8	51.92	26.20	20.98	11.89	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	17.66	29.09	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.78	25.02	23.79	7.93	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.48	19.18	18.71	4.99	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.85	21.64	16.23	5.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	14.82	6.70	4.94	4.23	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.15	28.37	18.87	5.56	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.45	19.23	21.82	4.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.90	23.15	22.60	5.27	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	32.72	28.17	29.35	7.63	0.00
Fibroblast - Lung, donor1	11270-116H1	9.52	5.44	4.08	4.08	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	41.78	16.41	13.43	0.00
Fibroblast - Lung, donor3	11419-118F6	13.72	19.42	11.18	3.17	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	50.81	16.66	18.33	11.66	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	22.38	15.38	6.99	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	45.34	14.83	6.16	6.72	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.06	22.73	19.08	11.37	0.00
Fibroblast - Mammary, donor2	11620-122A9	63.91	19.97	15.98	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	17.87	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	33.56	20.17	16.49	6.40	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	45.96	27.15	14.26	8.80	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.62	16.52	11.93	5.81	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.61	20.61	21.75	6.11	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.41	18.90	24.84	5.13	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	60.19	19.37	23.89	9.51	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.89	17.02	24.10	3.76	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	55.27	20.32	12.60	11.99	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	39.42	24.06	13.36	6.01	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	29.26	22.93	9.88	8.30	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.76	26.20	20.84	6.95	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	41.92	26.29	25.93	10.83	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.38	19.12	18.92	5.12	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	18.65	19.86	5.11	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	31.95	32.82	30.01	10.04	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	39.23	32.39	31.63	7.85	0.76
Fibroblast - skin normal, donor1	11553-120C5	33.31	20.35	29.37	7.22	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.66	23.46	18.05	5.21	0.00
Fibroblast - skin normal, donor2	11561-120D4	20.90	34.36	31.65	8.04	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	36.57	31.13	28.71	6.65	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	46.48	28.66	28.00	7.95	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	78.47	36.41	40.52	14.36	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	25.62	15.44	13.47	9.52	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.60	28.33	30.68	6.71	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	14.84	22.94	15.69	3.04	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.33	20.39	24.31	8.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	44.32	66.48	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	30.50	14.82	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.10	14.39	14.04	4.68	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.89	11.71	13.53	4.42	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.60	10.48	8.43	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	372.82	63.54	37.51	65.07	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	306.91	64.45	43.39	57.43	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	348.31	61.05	25.39	82.16	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	379.44	65.35	21.78	95.41	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	252.30	58.91	25.80	68.50	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	361.59	49.53	21.00	68.35	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	372.71	63.97	23.79	99.92	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	216.24	56.75	41.42	63.27	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	394.02	66.78	17.69	70.31	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	167.75	23.32	10.88	32.93	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	158.98	21.18	9.36	27.95	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	160.37	21.22	10.48	29.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	129.59	21.19	11.89	23.17	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	134.41	20.90	7.48	22.70	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	140.89	19.52	12.40	21.35	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	112.26	23.50	10.27	22.13	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	108.62	18.31	10.21	20.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	107.32	20.98	8.74	22.08	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	120.85	23.34	12.41	30.73	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	134.16	20.51	8.90	23.84	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	114.61	23.46	10.28	18.77	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	120.98	24.80	9.28	23.99	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	117.56	20.19	12.89	19.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	143.12	26.51	16.23	19.95	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	151.51	27.57	13.11	32.57	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	165.14	22.54	11.78	35.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	132.56	22.02	11.84	25.56	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	139.69	27.95	16.06	20.80	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	132.11	20.01	13.68	19.81	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	126.67	28.26	13.00	31.15	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	139.85	23.87	11.30	25.36	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	87.55	27.85	12.67	14.68	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	123.88	29.32	13.01	25.57	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	151.65	29.52	14.02	31.24	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	115.73	20.42	14.91	19.13	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	180.24	33.35	12.51	43.62	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	91.44	22.74	11.37	17.43	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	73.87	22.14	9.65	19.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	115.86	30.10	18.55	22.20	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	79.97	21.12	14.84	12.34	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	91.12	29.86	12.73	24.59	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	120.92	21.04	12.91	23.57	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	38.05	17.59	15.00	7.04	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	60.97	23.00	16.58	10.70	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.32	23.87	16.83	8.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.10	18.52	15.16	5.05	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	60.18	27.38	11.93	15.72	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	53.09	26.73	16.59	11.80	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	55.92	23.25	16.23	11.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	112.07	30.74	11.90	22.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.30	21.50	14.51	9.63	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.55	25.62	17.96	8.68	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	81.33	23.89	9.40	22.37	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	221.95	35.43	15.13	55.14	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	204.92	21.42	9.09	39.29	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	228.31	19.44	10.02	39.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	341.41	46.00	22.84	40.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	334.26	38.99	23.17	45.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	235.21	21.22	14.30	46.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	158.39	32.17	27.22	29.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	176.38	27.08	27.46	23.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	295.22	41.72	4.81	24.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	187.79	20.87	20.87	34.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	172.83	28.97	19.85	29.29	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	180.37	26.77	24.71	30.06	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	179.94	26.66	10.00	36.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	157.16	25.73	19.58	25.73	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	180.74	20.92	17.32	26.15	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	158.54	28.52	10.07	26.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	177.80	26.08	13.68	34.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	184.44	33.97	15.28	34.31	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	175.40	20.88	16.71	25.06	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	243.97	30.35	17.75	50.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	213.40	27.53	12.14	31.97	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	120.28	18.64	18.64	11.86	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	163.20	31.89	26.51	30.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	161.09	30.15	20.48	27.39	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	179.13	31.61	15.81	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	133.01	28.83	16.53	23.06	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	156.14	22.82	19.56	30.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	185.27	36.12	15.38	40.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	183.00	30.82	16.18	43.92	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	392.32	49.30	39.37	46.22	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	233.57	22.36	12.42	44.73	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	269.43	48.60	14.63	67.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	260.11	37.42	13.88	54.92	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	243.66	29.50	19.33	49.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	203.81	29.12	14.36	42.28	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	205.24	36.51	15.79	55.75	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	297.47	25.97	11.80	50.76	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	249.71	43.18	15.17	44.34	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	227.34	27.65	8.34	42.57	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	248.37	18.65	15.26	47.47	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	245.33	25.07	21.49	26.86	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	138.30	31.06	19.41	21.84	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	11.41	10.27	15.98	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.64	13.31	8.73	4.16	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	11.24	16.87	15.74	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.20	16.49	25.06	8.56	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.06	16.29	10.86	6.68	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	35.62	20.54	10.10	6.85	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.81	16.37	8.10	6.58	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	35.49	11.83	6.83	7.05	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.26	19.89	9.18	6.78	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	39.97	17.84	9.46	7.95	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	31.43	16.79	9.90	5.60	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.85	19.05	11.71	7.10	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	37.91	16.13	11.49	6.18	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	35.56	13.14	5.13	8.33	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	38.05	22.38	36.38	5.60	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	43.71	13.42	10.39	6.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	68.74	13.22	15.86	13.22	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	32.45	18.69	13.05	6.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	27.61	23.97	7.27	7.27	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.55	13.29	18.18	5.59	0.00
Hepatocyte, donor1	11523-119I2	64.16	9.68	7.26	15.74	0.00
Hepatocyte, donor2	11603-120I1	137.90	17.24	18.31	16.16	2.15
Hepatocyte, donor3	11684-122I1	59.51	13.50	14.72	6.75	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	54.83	37.86	43.73	5.87	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	103.30	12.93	9.61	14.33	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.85	19.62	9.60	7.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	60.49	9.55	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	6.68	13.35	20.03	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	55.38	19.38	4.15	12.46	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	22.52	0.00	22.52	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	178.02	47.47	35.60	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	20.50	10.25	20.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	9.14	9.14	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	92.59	16.24	11.37	8.12	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	71.69	20.01	8.34	18.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	98.03	18.15	14.52	25.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	56.91	1.32	13.23	13.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	73.17	22.17	7.76	13.30	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	10.48	15.71	31.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	80.62	21.42	11.34	19.53	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	10.83	12.37	12.37	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	29.27	14.63	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	76.23	14.86	9.69	11.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	64.40	6.44	11.27	9.66	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	11.95	0.00	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	88.82	20.37	8.15	7.33	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	43.66	13.01	5.88	8.40	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	28.74	0.00	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	77.96	16.07	19.29	12.86	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	66.48	20.31	13.85	4.62	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	30.16	30.16	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	91.10	18.41	10.86	15.11	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	48.98	16.33	15.42	12.70	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	44.23	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	73.18	12.91	8.61	9.69	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	54.63	12.70	16.52	12.70	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	16.43	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	71.42	15.30	14.67	11.48	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	7.29	16.40	7.29	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	15.80	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	57.13	16.42	16.42	10.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	0.00	19.91	33.18	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	73.15	17.28	15.43	12.04	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	7.02	10.54	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	106.87	3.14	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	48.68	8.34	4.87	7.65	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	110.65	24.34	2.21	22.13	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	9.73	29.18	29.18	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	105.50	21.80	20.05	16.57	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	139.49	36.00	22.50	24.75	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	94.08	31.36	10.45	20.91	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	94.94	21.34	14.93	22.40	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	78.97	6.93	9.70	11.08	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	39.89	2.85	5.70	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	83.76	17.49	13.81	18.41	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	24.20	12.10	21.18	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	6.21	12.42	37.25	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	101.51	24.32	5.29	26.43	1.06
Keratinocyte - epidermal, donor1	11272-116H3	33.13	11.67	5.06	4.98	0.00
Keratinocyte - epidermal, donor2	11349-117G8	31.04	8.20	6.44	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	31.99	17.70	8.80	4.92	0.00
Keratinocyte - oral, donor1	11251-116E9	32.13	24.41	11.92	11.24	0.00
Keratocytes, donor1	11527-119I6	309.45	70.49	44.70	34.73	0.00
Keratocytes, donor2	11607-120I5	60.93	18.75	8.20	11.72	0.00
Keratocytes, donor3	11688-122I5	96.43	39.91	28.65	19.17	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	15.39	24.18	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	26.97	15.10	6.47	9.71	0.00
Lens Epithelial Cells, donor2	11609-120I7	90.88	25.83	8.30	14.42	0.12
Lens Epithelial Cells, donor3	11690-122I7	56.91	26.03	22.81	12.92	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	41.74	16.84	20.99	5.57	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	37.40	19.26	22.33	4.47	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	39.51	17.47	22.04	6.77	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.04	9.68	18.28	4.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	36.56	20.17	21.43	5.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.08	14.99	16.60	5.93	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.83	12.72	22.98	4.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	45.76	20.23	18.46	4.80	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	29.84	14.64	16.61	5.21	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	48.25	15.03	23.34	5.14	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	62.04	18.42	27.34	6.40	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.59	14.81	12.96	3.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	46.34	16.38	24.74	4.53	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	51.52	18.84	20.51	4.53	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.53	12.64	17.86	5.63	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	58.20	15.71	30.18	8.93	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.53	24.63	13.40	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.01	13.72	15.37	4.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	41.47	15.80	23.70	4.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	42.47	17.57	19.04	4.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.12	16.18	18.17	3.98	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	44.13	17.46	30.07	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	67.05	23.16	28.81	6.46	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	37.69	14.23	20.13	3.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	55.99	16.07	30.07	6.22	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	74.75	21.99	24.29	4.40	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	32.18	16.84	14.74	4.21	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	54.34	19.95	33.02	5.50	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	77.33	24.84	27.28	6.59	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.38	16.01	16.01	4.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	49.43	16.48	24.71	5.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	77.07	24.48	27.79	7.94	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	38.41	14.99	18.83	4.83	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.72	15.55	20.73	5.18	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	67.95	21.74	24.96	6.42	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.72	16.09	13.75	5.50	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	49.53	17.69	27.66	6.43	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	82.78	24.65	29.82	8.22	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	46.89	22.25	29.39	4.76	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.02	14.22	25.60	4.98	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	96.47	20.36	22.78	5.82	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.57	14.32	17.12	4.67	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	39.75	12.18	29.01	3.22	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	93.76	17.31	24.50	7.84	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	27.31	11.77	16.95	3.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	48.14	21.53	21.66	5.82	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	67.11	24.08	19.47	6.66	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	39.98	8.65	19.69	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	15.86	9.06	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	28.38	14.58	9.97	3.84	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	11.88	7.42	5.20	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	31.73	18.62	6.77	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	18.29	5.63	3.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	15.88	5.60	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	31.43	16.49	8.24	7.21	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	11.89	5.95	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	27.37	16.51	7.92	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	43.91	21.52	10.76	6.40	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.66	21.16	10.35	7.65	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	35.36	18.56	12.19	5.28	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.89	21.05	10.78	7.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.05	13.41	11.64	4.59	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	27.98	9.99	10.66	7.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	39.73	20.88	11.21	6.11	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.82	16.81	9.61	6.94	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	45.91	18.33	13.98	6.05	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	24.54	20.86	11.04	3.07	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	29.36	22.83	5.71	4.08	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.90	21.87	12.70	5.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	50.17	28.03	10.93	6.45	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	31.94	12.36	8.24	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.90	21.19	14.52	6.68	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	47.53	26.31	14.05	3.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	33.20	18.81	9.96	6.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.88	16.61	13.08	4.24	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.42	19.55	14.01	6.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	10.36	10.36	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.61	18.80	13.82	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	38.50	17.55	11.89	2.83	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	36.10	11.49	8.20	5.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.05	16.27	9.49	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	33.75	18.67	7.90	5.03	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	39.59	18.67	5.23	8.22	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.04	18.58	8.92	8.55	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	36.18	19.81	12.92	9.48	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	10.28	11.13	3.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.65	18.32	10.00	5.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.04	19.31	10.26	4.22	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	35.55	9.24	13.51	4.27	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	36.09	18.56	8.59	5.16	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	35.96	15.57	12.88	5.90	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	40.40	17.51	7.41	3.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.12	24.45	12.59	6.67	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	15.12	8.14	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	38.08	14.81	6.35	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.21	15.61	10.80	3.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	40.70	21.08	8.72	6.54	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	30.66	15.33	4.60	7.67	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	30.09	16.77	12.33	6.41	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	23.52	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	31.17	18.60	10.56	6.54	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.11	12.17	10.36	5.41	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	17.21	13.77	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	35.18	12.91	11.13	6.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	37.15	13.69	11.73	5.08	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	39.58	20.45	11.88	6.60	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	30.62	13.49	6.23	6.75	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	23.63	12.25	9.19	6.13	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	43.05	21.80	10.62	7.83	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	37.54	10.60	10.16	4.42	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.71	18.51	13.11	3.86	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	44.05	20.76	11.65	7.60	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.97	15.38	8.65	4.81	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.15	23.85	8.75	5.57	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	55.90	24.30	13.37	14.58	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	24.21	11.07	9.68	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	36.48	16.34	11.78	6.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	49.06	16.01	13.94	6.71	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	39.30	21.77	15.12	7.86	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	41.20	19.33	9.19	6.02	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	47.44	21.32	12.79	5.86	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	39.08	22.41	16.67	7.47	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	44.74	19.03	15.94	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	60.13	24.05	11.32	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	55.05	20.43	17.59	7.94	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.84	15.81	10.40	4.16	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	45.42	28.19	17.23	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	43.42	22.97	13.78	9.19	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	39.03	19.51	10.69	5.11	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	45.50	24.09	16.06	5.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	45.98	19.25	14.97	4.28	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.18	18.99	12.12	5.25	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	64.24	17.44	12.85	7.34	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	52.46	26.67	12.45	4.45	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.01	14.82	7.41	5.70	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	58.28	13.04	14.57	4.60	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	44.32	20.79	15.32	6.57	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	35.19	16.93	9.80	4.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.61	18.46	12.48	4.68	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	25.86	10.61	4.64	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	39.49	20.79	6.24	6.24	2.08
Macrophage - monocyte derived, donor1	11232-116C8	10.94	23.48	30.77	1.82	0.00
Macrophage - monocyte derived, donor2	11313-117C8	26.98	16.33	23.12	2.75	0.18
Macrophage - monocyte derived, donor3	11389-118C3	8.52	18.61	22.55	1.57	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	11.15	16.46	4.25	0.00
Mallassez-derived cells, donor2	11929-125I3	28.20	11.09	15.21	3.96	0.16
Mallassez-derived cells, donor3	11930-125I4	31.69	11.40	13.62	5.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	57.20	46.04	16.54	9.27	0.20
Mammary Epithelial Cell, donor2	11350-117G9	45.75	24.32	20.27	5.21	0.00
Mammary Epithelial Cell, donor3	11422-118F9	10.48	14.47	7.23	3.24	0.00
Mast cell - stimulated, donor1	11487-119E2	31.19	43.39	90.17	7.46	0.00
Mast cell, donor1	11563-120D6	21.74	38.07	56.13	5.95	0.22
Mast cell, donor2	11565-120D8	71.92	37.74	33.58	11.29	0.59
Mast cell, donor3	11566-120D9	184.83	64.84	92.98	18.46	2.03
Mast cell, donor4	11567-120E1	61.70	35.81	44.68	10.64	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	46.69	43.69	45.47	9.32	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	32.10	49.61	46.69	7.59	0.00
Mast cell, expanded, donor5	11939-126A4	23.86	42.68	52.54	9.18	0.23
Mast cell, expanded, donor8	11941-126A6	14.06	39.33	30.63	9.04	0.17
Melanocyte - dark, donor1	11502-119F8	56.91	14.43	13.53	7.06	0.10
Melanocyte - dark, donor2	11582-120F7	53.30	22.50	33.92	7.96	0.00
Melanocyte - dark, donor3	11663-122F7	23.69	24.70	17.10	4.56	0.07
Melanocyte - light, donor1	11274-116H5	18.10	10.81	7.52	2.82	0.00
Melanocyte - light, donor2	11351-117H1	9.55	14.33	4.78	3.41	0.00
Melanocyte - light, donor3	11423-118G1	19.08	6.07	7.81	4.34	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	34.47	14.58	19.99	4.89	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	19.90	14.52	16.41	4.30	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	56.25	21.70	15.00	12.05	0.00
Meningeal Cells, donor1	11493-119E8	65.38	40.32	26.67	12.41	0.12
Meningeal Cells, donor2	11573-120E7	74.38	36.09	25.97	13.64	0.00
Meningeal Cells, donor3	11654-122E7	38.06	29.10	20.05	6.60	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	31.37	25.95	19.11	5.42	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.18	22.14	25.46	10.06	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	11.83	6.57	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	14.39	3.92	7.85	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	14.35	24.40	3.59	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	46.17	17.79	17.36	6.35	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	33.68	16.59	15.08	8.54	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	39.78	28.79	14.06	8.79	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	31.42	16.80	9.50	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	31.10	20.66	12.07	6.14	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.78	39.47	27.42	10.25	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	50.93	7.06	8.18	7.43	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	64.34	27.50	18.95	13.29	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	48.37	22.26	19.58	16.32	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	60.72	39.70	7.01	30.36	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	25.62	13.45	10.25	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	17.37	23.04	21.98	4.96	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.96	19.08	18.14	7.19	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.14	14.51	22.50	5.08	0.00
Mesothelial Cells, donor1	11247-116E5	99.44	20.42	27.84	11.67	0.00
Mesothelial Cells, donor2	12156-128G5	30.53	15.01	13.01	4.00	0.00
Mesothelial Cells, donor3	11402-118D7	34.47	14.53	13.44	4.48	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	58.06	14.85	9.45	9.45	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.39	24.63	43.59	8.87	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.39	19.43	27.97	6.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	23.87	21.39	32.54	2.79	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	28.83	18.88	19.50	4.36	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	6.95	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	45.80	21.77	35.79	5.01	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	34.91	13.03	23.74	3.26	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.89	22.76	35.36	5.28	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.60	20.19	22.57	3.96	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	12.39	27.43	4.42	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.59	23.94	37.99	4.94	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	2.63	9.21	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.60	20.59	29.07	6.15	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	38.67	11.05	7.37	5.52	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	58.12	19.08	36.96	5.96	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	1.68	6.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	71.01	27.35	53.69	8.03	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	61.56	16.87	25.19	5.70	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	6.08	16.03	1.11	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	90.72	20.95	52.96	9.67	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	64.57	21.03	30.50	6.31	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	75.62	17.73	35.06	5.91	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	75.95	19.09	53.42	8.80	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	63.80	14.45	27.56	5.11	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	88.92	19.05	39.42	8.76	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	59.82	8.11	13.69	2.03	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	34.80	1.66	3.31	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	97.85	19.84	47.02	10.06	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	71.46	17.06	26.76	6.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	38.16	5.45	7.63	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	83.62	18.26	27.87	9.61	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	58.03	18.41	36.42	6.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	61.70	10.97	16.45	13.71	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	61.07	14.02	25.03	7.01	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	26.95	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	30.58	2.04	2.04	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	60.43	15.77	32.41	9.20	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	41.94	9.93	17.66	4.41	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	3.20	5.76	3.20	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	60.99	20.33	27.77	6.69	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	27.14	7.65	17.40	2.78	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	49.91	10.94	22.56	8.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	27.13	6.56	12.25	4.81	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	23.44	12.07	12.07	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	47.41	20.48	29.74	6.45	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	21.61	7.48	13.72	4.16	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.23	2.91	5.24	2.91	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.23	13.88	24.74	5.73	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.31	18.78	31.30	4.59	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	45.25	19.39	30.48	4.62	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	44.39	17.64	33.01	13.66	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	54.03	14.37	20.17	5.11	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	60.38	18.14	31.88	8.29	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	64.35	15.01	22.74	7.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.00	6.35	4.45	7.62	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	62.19	14.41	21.62	7.47	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	124.82	30.83	46.99	15.27	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	110.18	15.68	22.60	11.87	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	94.28	22.93	37.58	11.15	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	79.61	25.43	39.36	10.61	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	68.26	12.51	12.89	7.58	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	107.39	20.74	47.45	11.08	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	126.59	38.84	54.08	15.73	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	119.26	9.78	18.25	12.38	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	187.59	23.52	55.57	18.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	185.68	36.04	47.29	20.47	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	259.65	28.44	45.34	24.32	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	121.50	17.27	36.93	12.80	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	22.60	48.97	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	23.17	26.73	5.35	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	37.46	23.99	27.60	8.87	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	18.94	24.19	5.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.47	39.54	49.82	9.69	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	32.60	26.08	35.39	17.70	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	26.29	31.17	38.68	9.01	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.30	20.77	33.56	3.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.05	15.38	26.47	5.32	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.00	23.58	23.58	8.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	31.15	21.62	23.08	6.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	26.45	23.33	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	25.65	41.15	6.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	23.18	15.46	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	30.30	20.20	22.22	9.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	42.59	29.94	37.10	6.32	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	17.71	17.71	10.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	56.59	33.70	38.78	15.89	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	59.93	29.15	25.10	12.96	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	25.68	34.74	9.06	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	17.13	17.13	22.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	140.29	29.36	55.46	22.84	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	14.26	61.78	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	37.65	37.65	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	55.80	22.84	27.36	9.26	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	75.78	37.11	24.04	19.86	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	30.70	14.68	8.68	7.34	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	11.27	8.35	6.26	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	34.61	42.40	22.63	15.02	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	23.94	23.94	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	8.16	10.88	8.16	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	9.19	11.03	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.13	22.60	10.46	12.56	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.27	25.80	19.06	10.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.59	22.97	11.89	12.70	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.84	25.23	23.34	10.93	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.91	26.31	7.45	8.93	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	33.83	47.91	28.42	21.92	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.75	21.99	14.28	17.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	46.70	30.37	17.47	11.43	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	42.10	23.69	24.24	8.93	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	25.99	18.57	18.03	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	17.41	16.81	16.21	8.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	39.05	45.94	23.96	23.30	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.66	15.61	13.01	9.92	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	45.68	18.70	21.17	11.82	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	31.65	21.10	14.06	18.28	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	24.36	31.72	27.58	11.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	54.63	21.85	16.07	14.14	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.39	38.28	22.42	21.73	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	12.64	12.64	10.11	12.64	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.90	21.39	19.16	10.25	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	49.11	28.37	27.10	14.82	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.09	42.01	27.30	11.39	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	57.52	28.76	24.90	13.74	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	77.97	21.33	12.00	11.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	59.06	16.68	17.13	8.12	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	67.85	30.95	25.79	17.86	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	30.65	13.00	10.22	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.59	49.95	38.59	20.43	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	67.46	21.83	15.64	8.47	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	73.21	22.23	7.41	10.02	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	62.42	22.16	14.93	11.76	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	94.36	24.69	23.81	17.64	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.93	25.26	15.96	7.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	79.86	35.22	17.86	16.37	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	70.44	17.23	13.40	14.55	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	40.53	35.39	16.94	13.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.51	17.68	13.92	11.49	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	68.44	23.72	26.43	19.65	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	5.11	15.33	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	79.87	28.05	17.68	17.68	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	66.09	18.25	13.85	16.37	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	65.37	19.37	11.20	15.13	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	46.68	26.11	20.57	19.78	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	55.55	53.28	37.41	22.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	20.23	15.17	5.06	5.06
Myoblast, donor1	11241-116D8	14.53	12.55	16.27	3.60	0.00
Myoblast, donor2	11322-117D8	25.89	19.56	19.75	5.95	0.00
Myoblast, donor3	11398-118D3	16.82	15.81	16.98	3.53	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	34.59	21.89	10.36	8.90	0.00
Natural Killer Cells, donor1	11230-116C6	97.48	39.36	47.05	7.07	1.54
Natural Killer Cells, donor2	11311-117C6	111.88	44.93	55.18	21.71	2.11
Natural Killer Cells, donor3	11387-118C1	113.93	45.83	40.49	13.44	2.39
Neural stem cells, donor1	11275-116H6	145.90	32.30	15.24	18.87	0.00
Neural stem cells, donor2	11352-117H2	510.30	9.63	19.26	40.44	0.00
Neurons, donor1	11494-119E9	650.88	23.90	54.62	45.52	1.14
Neurons, donor2	11574-120E8	476.43	24.88	21.80	40.73	0.22
Neurons, donor3	11655-122E8	1160.90	88.79	71.53	93.73	1.64
Neutrophils, donor1	11233-116C9	81.66	32.48	30.62	17.63	0.00
Neutrophils, donor2	11314-117C9	55.08	26.09	2.90	17.39	0.00
Neutrophils, donor3	11390-118C4	142.33	36.04	32.37	37.87	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	45.71	27.78	17.57	12.11	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	39.72	39.72	11.72	9.77	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	47.13	33.89	19.65	10.03	0.00
Olfactory epithelial cells, donor1	11933-125I7	64.70	43.77	26.57	14.04	0.28
Olfactory epithelial cells, donor2	11934-125I8	47.33	37.05	28.08	12.59	0.43
Olfactory epithelial cells, donor3	11935-125I9	62.20	44.04	32.80	15.32	0.23
Olfactory epithelial cells, donor4	11936-126A1	54.25	29.80	19.77	11.79	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	46.34	15.65	17.45	10.23	0.00
Osteoblast - differentiated, donor1	11276-116H7	45.73	25.31	24.67	9.57	0.00
Osteoblast - differentiated, donor2	11353-117H3	33.15	27.43	20.58	8.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	39.10	30.41	8.69	12.41	0.00
Osteoblast, donor1	11277-116H8	36.74	46.51	28.34	10.55	0.00
Osteoblast, donor2	11354-117H4	42.84	31.60	15.45	7.02	0.00
Osteoblast, donor3	11426-118G4	21.68	23.64	12.62	2.67	0.00
Pancreatic stromal cells, donor1	11249-116E7	19.46	24.18	23.00	5.90	0.08
Pericytes, donor1	11491-119E6	73.99	31.04	8.79	18.36	0.00
Pericytes, donor2	11571-120E5	61.12	28.52	11.09	14.03	0.00
Pericytes, donor3	11652-122E5	43.95	20.34	17.29	6.51	0.00
Perineurial Cells, donor1	11499-119F5	49.84	19.55	14.35	10.74	0.00
Perineurial Cells, donor2	11579-120F4	70.02	26.50	31.28	11.13	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	155.23	39.52	27.73	20.08	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	164.55	35.02	30.36	16.16	1.96
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	74.54	38.70	36.62	10.35	0.65
Placental Epithelial Cells, donor1	11278-116H9	50.22	11.24	8.37	4.30	0.00
Placental Epithelial Cells, donor2	11355-117H5	37.70	13.31	8.87	4.44	0.00
Placental Epithelial Cells, donor3	11427-118G5	18.06	11.58	5.89	5.69	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.47	17.40	21.20	8.86	0.00
Preadipocyte - breast, donor1	11467-119B9	42.77	26.07	26.45	6.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	28.45	18.93	21.67	5.09	0.00
Preadipocyte - breast, donor2	11328-117E5	21.39	20.26	19.14	4.95	0.23
Preadipocyte - omental, donor1	11468-119C1	65.85	24.62	28.98	14.17	0.32
Preadipocyte - omental, donor2	11329-117E6	45.39	20.51	24.88	10.48	0.00
Preadipocyte - omental, donor3	11403-118D8	26.07	17.48	18.05	7.59	0.00
Preadipocyte - perirenal, donor1	11469-119C2	35.43	15.75	9.84	7.87	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.96	18.12	19.35	3.38	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	24.97	26.21	19.66	4.96	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	16.52	17.71	16.35	3.75	0.17
Preadipocyte - visceral, donor1	11280-116I2	27.57	26.64	19.28	5.50	0.00
Preadipocyte - visceral, donor2	11357-117H7	30.83	23.93	18.87	7.82	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.39	26.65	18.81	4.18	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	98.81	12.37	8.30	11.31	0.15
Prostate Epithelial Cells, donor2	11331-117E8	17.47	11.24	7.58	3.11	0.00
Prostate Epithelial Cells, donor3	11404-118D9	67.91	19.29	8.51	12.92	0.00
Prostate Stromal Cells, donor1	11254-116F3	43.85	22.10	20.96	5.70	0.11
Prostate Stromal Cells, donor2	11332-117E9	52.00	29.40	25.64	10.58	0.00
Prostate Stromal Cells, donor3	11405-118E1	28.99	17.10	16.89	7.30	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	54.38	20.07	9.49	14.60	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	63.91	20.79	12.48	10.33	0.00
Renal Epithelial Cells, donor1	11517-119H5	33.98	11.16	1.52	7.10	0.00
Renal Epithelial Cells, donor2	11597-120H4	25.61	29.88	8.54	6.40	0.00
Renal Epithelial Cells, donor3	11678-122H4	46.47	18.84	12.70	10.80	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	37.45	18.38	16.34	2.72	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	41.24	25.61	26.14	7.28	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.09	19.09	20.42	3.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.97	11.98	5.99	3.99	0.00
Renal Mesangial Cells, donor1	11518-119H6	46.66	18.71	7.92	8.80	0.00
Renal Mesangial Cells, donor2	11598-120H5	42.63	22.57	10.66	12.54	0.00
Renal Mesangial Cells, donor3	11679-122H5	25.52	13.32	3.33	5.27	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.44	15.30	10.20	8.86	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	46.81	10.96	8.86	7.59	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	29.12	16.58	7.71	6.17	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	58.86	16.08	9.59	7.26	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	67.37	20.75	9.95	20.47	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	43.22	11.32	4.12	10.29	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	264.21	31.36	19.32	25.09	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	125.75	29.80	24.19	13.90	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	28.59	21.44	13.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	91.91	60.54	60.54	26.97	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	73.09	44.08	45.82	30.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	48.50	31.86	23.79	10.79	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.03	26.61	16.68	7.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	40.49	28.67	16.17	7.58	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.25	27.79	15.63	7.81	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.57	27.50	18.18	7.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	46.92	31.43	18.72	10.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	44.08	23.69	13.42	11.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.31	27.23	15.43	7.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.42	20.07	16.84	8.78	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	48.78	29.55	16.07	11.48	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	34.23	22.86	13.09	6.98	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	40.49	24.56	13.72	8.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.82	22.94	14.91	14.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	33.73	22.45	14.25	5.40	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	44.91	28.94	17.10	9.96	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	44.99	27.74	19.64	12.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	26.67	22.68	13.04	6.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	36.66	30.17	17.38	7.26	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	40.26	27.13	17.83	9.93	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	30.27	20.74	11.21	9.25	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	29.91	18.46	12.82	5.30	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	41.39	24.43	18.78	9.85	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.94	20.48	13.98	6.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.86	20.69	12.36	6.18	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	50.71	29.01	22.64	11.56	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	36.71	23.21	16.67	6.94	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.03	25.49	20.11	8.89	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	43.13	30.07	24.05	8.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	32.96	23.23	14.82	8.63	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	35.72	23.60	12.74	7.73	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	44.41	31.22	22.34	11.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	31.67	26.40	14.48	5.62	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.19	27.38	15.23	5.98	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	42.64	29.40	19.94	9.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.63	21.81	16.87	6.04	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	41.37	28.57	21.51	8.37	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.76	25.05	18.24	10.57	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	30.92	27.37	16.42	5.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	41.85	26.12	17.06	4.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	66.64	33.74	23.09	20.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.62	31.19	10.95	8.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	53.81	24.79	14.11	11.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.76	37.58	24.20	15.92	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	47.16	38.08	26.20	20.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	28.11	33.55	22.06	10.58	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.10	41.98	23.99	15.18	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	66.95	41.19	28.67	14.26	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	34.07	29.81	13.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	40.99	37.67	25.92	13.26	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	43.88	38.45	20.36	14.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	64.40	37.14	24.56	14.38	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	45.46	43.45	40.62	13.81	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.90	28.82	28.60	10.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	52.29	34.26	24.64	12.02	0.00
Schwann Cells, donor1	11498-119F4	43.44	27.08	9.22	9.40	0.00
Schwann Cells, donor2	11578-120F3	30.62	23.82	30.62	3.40	0.00
Schwann Cells, donor3	11659-122F3	27.60	16.43	13.58	4.60	0.00
Sebocyte, donor1	11220-116B5	24.65	11.50	7.67	3.29	0.00
Sebocyte, donor2	11301-117B5	22.06	11.95	4.60	2.76	0.00
Sebocyte, donor3	11378-118B1	19.37	8.86	7.42	4.95	0.00
Sertoli Cells, donor1	11255-116F4	39.76	21.54	23.19	1.66	0.00
Sertoli Cells, donor2	11333-117F1	33.89	28.24	16.95	14.12	0.00
Skeletal Muscle Cells, donor1	11281-116I3	111.47	33.96	21.82	16.28	0.00
Skeletal Muscle Cells, donor2	11358-117H8	39.76	15.90	13.73	11.57	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	24.25	18.39	5.85	0.00
Skeletal Muscle Cells, donor4	11451-119A2	36.76	24.04	22.46	7.07	0.00
Skeletal Muscle Cells, donor5	11455-119A6	38.05	26.76	19.32	5.95	0.15
Skeletal Muscle Cells, donor6	11459-119B1	43.09	29.24	26.01	7.85	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.38	32.13	29.99	8.69	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.98	20.40	17.69	6.56	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	35.42	21.43	16.27	6.75	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	62.26	28.14	19.04	9.94	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	77.44	24.61	20.99	10.86	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.15	28.35	15.14	5.09	0.00
Skin - palm, donor1	10286-104F7	40.29	29.55	21.49	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.87	8.22	9.51	3.60	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	8.18	30.26	9.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.06	9.61	10.91	4.80	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	50.88	24.19	19.60	5.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	46.42	20.40	12.80	6.75	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.72	16.07	18.82	3.59	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	83.57	21.44	11.92	9.52	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	40.42	23.76	21.91	18.21	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.46	18.01	18.23	10.23	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	10.58	11.17	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	53.04	21.88	15.25	4.86	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.41	12.99	11.42	4.33	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	16.22	18.54	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	77.06	25.02	22.02	17.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	27.95	13.97	16.37	7.19	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.13	25.05	22.17	7.98	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.02	13.19	26.25	4.23	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	22.79	16.93	17.26	1.95	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	28.06	15.36	11.22	7.09	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.35	11.96	8.40	5.84	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	32.37	12.85	7.16	7.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	102.90	30.44	19.79	12.18	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	24.75	18.94	15.91	8.08	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	6.12	12.24	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.32	18.12	11.92	9.54	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.92	14.75	15.63	3.69	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.04	20.23	11.62	8.39	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	23.09	15.43	12.39	4.83	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.14	16.24	16.71	6.03	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	7.55	8.62	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.23	19.43	19.43	3.59	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	46.77	14.34	6.83	7.17	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	31.18	28.98	14.61	7.46	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	31.40	11.88	10.47	5.74	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.12	18.89	27.31	9.78	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	30.79	30.19	25.96	7.85	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	63.85	28.88	12.45	8.48	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	44.34	32.22	26.90	9.72	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	42.32	22.29	21.79	11.77	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.01	16.74	19.79	5.83	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.03	22.92	20.96	4.37	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	18.75	18.75	7.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	64.61	171.86	12.92	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.72	13.95	13.02	6.05	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	26.25	8.58	9.09	5.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.99	14.73	20.06	5.01	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	32.15	12.68	3.24	6.19	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.33	18.08	11.66	4.58	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	19.15	17.28	7.01	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	26.91	17.70	14.68	3.17	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.32	20.65	12.24	3.82	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.08	24.07	20.12	4.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.76	27.53	15.51	5.73	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	33.43	19.19	23.96	9.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	44.28	17.14	7.14	18.09	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	19.33	11.74	16.39	3.91	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	50.38	28.06	22.76	13.48	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.29	17.85	18.73	3.22	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	37.90	20.99	23.32	6.03	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.76	21.42	28.56	7.93	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	28.64	36.45	15.99	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	64.68	13.65	26.23	11.50	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.36	8.52	13.91	5.68	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	39.78	25.60	24.42	8.27	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	45.71	19.30	30.73	11.94	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	67.09	20.76	21.16	19.57	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.00	19.23	25.08	14.21	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	53.17	20.17	26.13	10.54	0.00
Synoviocyte, donor1	11291-117A4	49.49	28.11	20.87	8.58	0.00
Synoviocyte, donor2	11368-117I9	30.51	23.97	26.82	8.38	0.00
Synoviocyte, donor3	11440-118H9	71.94	35.30	28.82	17.20	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	73.61	20.01	15.01	13.94	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	216.04	29.73	5.95	25.77	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	97.25	34.04	12.50	18.06	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	55.56	26.74	14.12	6.88	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	6.19	5.80	2.71	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	28.63	12.60	9.74	3.44	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	123.76	31.37	27.31	14.15	0.37
Urethra, donor2	10319-105A4	106.11	32.37	35.97	10.79	0.00
Urothelial Cells, donor1	11520-119H8	27.89	11.95	4.52	6.11	0.00
Urothelial Cells, donor2	11600-120H7	14.02	11.22	5.21	3.61	0.00
Urothelial Cells, donor3	11681-122H7	15.82	11.69	4.58	4.58	0.00
Urothelial cells, donor0	11216-116B1	25.19	24.52	11.37	10.48	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	3011.92	77.41	83.64	211.77	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	3439.64	81.49	77.20	243.03	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	1820.14	44.49	34.23	150.59	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	1301.60	43.39	44.08	95.73	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	1142.88	48.23	51.71	76.11	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	2535.42	65.60	60.39	153.06	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	2886.46	68.83	74.34	189.98	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	1667.87	50.21	42.91	110.46	0.91
Wilms' tumor cell line:G-401	10809-111A8	90.30	34.29	16.41	16.53	0.25
Wilms' tumor cell line:HFWT	10597-108E3	169.85	28.16	10.56	14.96	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	76.81	27.09	10.33	12.01	0.00
achilles tendon, donor2	10292-104G4	117.79	26.86	20.67	14.47	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	113.46	35.95	9.43	24.22	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	124.21	45.51	14.63	25.31	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	44.04	29.32	14.60	7.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	32.11	62.59	39.18	12.25	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	92.76	34.85	19.39	17.71	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	17.55	38.28	37.01	6.77	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.62	20.14	26.40	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.01	25.56	18.51	12.34	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	38.79	39.20	42.88	5.72	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	59.02	49.31	24.46	14.37	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	36.06	26.31	16.38	10.49	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	46.81	50.71	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.82	38.58	23.01	6.04	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	62.65	51.26	26.93	16.83	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.39	33.61	15.78	14.90	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	23.24	13.48	7.90	6.04	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.08	29.61	27.14	4.52	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	27.01	19.95	13.20	6.75	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	17.92	35.84	18.35	4.27	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	15.16	22.75	16.38	2.73	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	23.59	25.27	16.61	3.85	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	34.97	19.16	16.48	9.13	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	163.44	31.35	55.04	14.34	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	87.34	22.30	16.72	11.15	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	26.74	25.61	53.49	5.65	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.45	35.76	24.86	10.90	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	26.24	28.12	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	84.07	40.27	17.66	15.31	0.00
adipose tissue, adult, pool1	10010-101C1	46.69	24.35	24.20	8.22	0.00
adipose, donor1	10184-103D4	180.03	72.13	15.83	64.51	1.17
adipose, donor2	10185-103D5	463.51	82.73	22.30	100.97	1.22
adipose, donor3	10186-103D6	224.09	50.37	29.13	56.64	0.00
adipose, donor4	10187-103D7	179.42	32.94	15.60	33.80	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	99.43	41.35	6.94	28.88	0.16
adrenal gland, adult, pool1	10081-102A9	145.51	25.46	32.74	21.83	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	23.21	32.15	22.41	5.60	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	30.01	46.09	25.73	10.36	0.00
amniotic membrane cells, donor1	12235-129G3	27.36	19.71	25.27	8.35	0.46
amniotic membrane cells, donor2	12236-129G4	32.12	26.03	19.95	9.13	0.00
amniotic membrane cells, donor3	12237-129G5	22.39	27.99	15.02	9.13	0.29
amygdala - adult, donor10196	10167-103B5	520.57	29.64	18.97	60.48	1.19
amygdala, adult, donor10252	10151-102I7	342.07	44.20	41.16	46.23	0.81
amygdala, newborn, donor10223	10360-105E9	258.54	29.37	37.12	29.05	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	58.83	24.83	26.48	15.02	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	31.77	43.24	19.86	13.02	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	159.34	33.40	10.69	28.39	0.33
aorta, adult, pool1	10052-101G7	122.58	39.42	32.75	18.83	0.20
appendix, adult	10189-103D9	66.37	38.81	45.41	16.30	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	187.10	30.95	21.67	41.96	0.00
artery, adult	10190-103E1	156.25	14.95	19.02	19.02	1.36
astrocytoma cell line:TM-31	10425-106D2	100.54	34.33	22.45	12.60	0.43
b cell line:RPMI1788	10427-106D4	135.17	33.31	8.03	29.89	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	50.22	16.92	29.96	6.94	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	14.79	12.60	8.43	3.57	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	143.44	31.30	19.92	11.38	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	45.86	46.42	31.32	18.45	0.56
bladder, adult, pool1	10011-101C2	141.78	31.83	24.01	20.86	0.00
blood, adult, pool1	10053-101G8	967.79	46.51	33.22	101.87	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	6.85	20.55	0.00	0.00
bone marrow, adult	10192-103E3	49.26	30.37	31.04	10.12	0.00
brain, adult, donor1	10084-102B3	176.31	49.20	37.93	44.08	0.00
brain, adult, pool1	10012-101C3	245.66	25.17	27.17	29.40	0.33
brain, fetal, pool1	10085-102B4	566.34	53.43	50.76	138.91	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.03	22.13	10.24	4.63	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	98.49	28.09	19.85	10.98	0.00
breast, adult, donor1	10080-102A8	172.36	38.51	29.04	31.57	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.74	28.96	4.57	6.99	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	56.90	25.97	9.59	9.28	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.97	49.50	15.19	11.74	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.10	16.22	5.81	3.39	0.24
carcinoid cell line:NCI-H1770	10703-109H1	132.59	7.99	6.11	11.28	0.47
carcinoid cell line:NCI-H727	10735-110B6	43.31	16.52	8.20	5.80	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	189.82	40.88	16.48	51.02	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	157.84	70.00	40.73	40.19	0.27
caudate nucleus - adult, donor10196	10177-103C6	435.20	25.33	34.54	52.96	0.00
caudate nucleus, adult, donor10252	10164-103B2	324.28	42.67	48.02	35.47	1.00
caudate nucleus, adult, donor10258	10379-105H1	325.52	35.15	33.62	35.15	0.76
caudate nucleus, newborn, donor10223	10354-105E3	326.68	36.62	34.79	35.89	1.10
cerebellum - adult, donor10196	10173-103C2	632.18	52.44	61.18	90.31	2.91
cerebellum, adult, donor10252	10166-103B4	501.96	57.22	44.20	53.38	1.07
cerebellum, adult, pool1	10083-102B2	452.22	65.54	47.26	70.71	0.00
cerebellum, newborn, donor10223	10357-105E6	253.24	48.99	42.34	37.36	0.00
cerebral meninges, adult	10188-103D8	160.36	39.59	58.24	32.78	0.25
cerebrospinal fluid, donor2	10294-104G6	279.20	15.35	32.16	21.20	0.73
cervical cancer cell line:D98-AH2	10552-107I3	155.43	63.98	22.00	30.63	0.29
cervical cancer cell line:ME-180	10553-107I4	59.82	18.56	13.75	8.45	0.00
cervix, adult, pool1	10013-101C4	87.88	28.56	24.36	14.59	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	132.65	30.10	40.83	14.07	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	13.06	6.53	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	69.84	31.57	7.21	14.29	0.12
choriocarcinoma cell line:SCH	10785-110H2	265.52	21.19	7.64	30.06	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	57.16	19.69	6.17	11.15	0.24
chorionic membrane cells, donor1	12238-129G6	56.41	21.94	31.34	11.68	0.00
chorionic membrane cells, donor2	12239-129G7	36.59	16.41	15.51	5.57	0.10
chorionic membrane cells, donor3	12240-129G8	34.62	35.72	26.92	9.34	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	31.30	32.31	4.04	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.12	30.35	27.47	6.92	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	28.51	23.44	24.92	6.12	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	189.78	27.99	14.64	32.10	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	192.78	38.94	15.24	45.47	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	150.67	40.72	18.94	36.85	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	171.37	44.46	18.26	25.91	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	65.16	24.76	27.89	11.21	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.60	20.34	10.97	8.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	32.10	14.23	8.50	6.59	0.00
colon carcinoma cell line:CACO-2	10513-107D9	108.18	23.25	9.52	18.30	0.18
colon carcinoma cell line:COLO-320	10420-106C6	159.63	23.18	3.42	38.77	0.00
colon, adult, donor1	10082-102B1	73.78	36.89	30.94	13.09	0.00
colon, adult, pool1	10014-101C5	82.49	31.49	38.07	14.92	0.35
colon, fetal, donor1	10070-101I7	116.80	77.25	50.68	24.72	1.24
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00	9.17	13.75	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	25.04	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	74.79	42.49	34.42	9.77	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	48.30	54.64	31.70	8.15	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	41.88	48.51	29.19	8.88	0.00
corpus callosum, adult, pool1	10042-101F6	219.58	26.31	16.47	22.00	0.22
cruciate ligament, donor2	10295-104G7	132.92	37.28	50.25	12.97	0.81
diaphragm, fetal, donor1	10069-101I6	161.32	31.30	24.08	20.06	0.00
diencephalon, adult	10193-103E4	212.87	19.68	24.00	25.92	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	101.26	25.26	8.27	26.18	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.13	17.69	9.49	10.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	51.27	18.05	15.41	13.00	0.00
ductus deferens, adult	10196-103E7	54.32	42.36	27.41	7.48	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	122.42	74.89	14.40	34.57	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	78.71	34.58	20.60	17.66	0.74
dura mater, adult, donor1	10041-101F5	60.54	29.15	18.50	6.69	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	138.13	15.99	16.66	14.88	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	74.08	22.07	11.18	13.33	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	127.02	51.18	38.23	20.35	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	62.06	43.29	28.15	11.50	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	116.40	46.93	39.52	16.67	0.00
embryonic pancreas cell line:2C6	10603-108E9	115.58	22.33	38.09	9.19	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	217.54	44.58	17.77	25.14	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	109.47	67.24	38.42	16.85	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.16	9.81	11.26	4.02	0.00
epidermoid carcinoma cell line:A431	10426-106D3	23.79	8.67	7.78	3.45	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	19.58	14.41	6.38	5.17	0.00
epididymis, adult	10197-103E8	56.93	29.93	25.75	8.79	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	50.56	41.16	17.56	8.87	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.48	14.16	8.26	2.75	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.95	23.85	12.19	4.98	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.55	37.20	15.75	12.99	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	42.46	21.17	8.85	5.15	0.34
esophagus, adult, pool1	10015-101C6	60.42	26.23	19.96	10.30	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	93.18	55.86	29.93	31.06	0.25
eye - muscle inferior rectus, donor1	10272-104E2	149.70	31.39	43.46	24.15	4.83
eye - muscle lateral, donor2	10298-104H1	162.02	16.83	18.94	14.73	0.00
eye - muscle medial, donor2	10299-104H2	120.55	14.88	11.91	11.91	1.49
eye - muscle superior, donor2	10297-104G9	115.80	17.20	29.81	10.32	1.15
eye - vitreous humor, donor1	10268-104D7	62.67	14.57	23.32	8.74	0.00
eye, fetal, donor1	10054-101G9	175.93	43.47	23.90	23.90	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	27.44	29.88	25.90	8.46	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	81.91	41.07	33.24	17.09	0.00
frontal lobe, adult, pool1	10040-101F4	292.64	36.22	29.27	37.81	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	74.16	33.33	14.11	11.41	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.49	28.16	10.52	12.16	0.00
gall bladder, adult	10198-103E9	41.77	26.80	27.76	9.90	0.00
gamma delta positive T cells, donor1	11937-126A2	48.32	41.87	49.93	16.11	0.54
gamma delta positive T cells, donor2	11938-126A3	39.22	29.51	47.43	15.31	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.68	10.98	7.82	5.70	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.96	22.44	10.06	11.02	0.19
gastric cancer cell line:AZ521	10549-107H9	111.98	38.53	18.53	25.58	0.00
gastric cancer cell line:GSS	10560-108A2	192.20	54.00	9.15	33.86	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	410.77	24.44	13.94	39.98	0.69
giant cell carcinoma cell line:LU65	10487-107B1	113.59	27.08	13.65	12.74	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	61.86	32.33	17.77	20.29	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.66	28.18	10.48	7.48	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.15	11.19	10.56	2.22	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.99	14.32	13.06	3.37	0.00
glioblastoma cell line:T98G	10485-107A8	19.20	26.60	20.64	3.97	0.00
glioma cell line:GI-1	10413-106B8	46.86	33.10	10.25	16.69	0.00
globus pallidus - adult, donor10196	10175-103C4	513.88	26.24	29.89	48.84	0.00
globus pallidus, adult, donor10252	10161-103A8	249.46	30.51	27.34	27.09	0.49
globus pallidus, adult, donor10258	10367-105F7	115.01	15.06	41.08	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	238.75	19.72	25.05	17.59	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	12.24	2.45	9.79	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	10.45	10.45	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	38.08	14.08	10.88	6.40	0.00
hIPS +CCl2, biol_rep1	14383-156B9	340.20	21.12	9.18	55.09	0.00
hIPS +CCl2, biol_rep2	14384-156C1	285.79	15.55	15.55	59.90	0.46
hIPS +CCl2, biol_rep3	14385-156C2	349.10	10.31	10.31	67.63	0.00
hIPS, biol_rep1	14380-156B6	343.51	4.31	1.44	90.55	0.00
hIPS, biol_rep2	14381-156B7	314.13	6.86	12.35	54.18	0.00
hIPS, biol_rep3	14382-156B8	420.42	16.55	18.76	56.28	0.00
hairy cell leukemia cell line:Mo	10712-109I1	51.43	35.06	12.36	8.05	0.00
heart - mitral valve, adult	10205-103F7	375.80	26.31	38.87	32.29	0.00
heart - pulmonic valve, adult	10206-103F8	413.13	31.90	32.95	28.76	1.05
heart - tricuspid valve, adult	10207-103F9	216.49	29.98	37.47	21.65	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	566.67	31.42	18.77	40.20	0.00
heart, adult, diseased, donor1	10051-101G6	1356.28	34.07	38.75	96.24	0.43
heart, adult, pool1	10016-101C7	952.80	25.99	48.76	53.12	0.69
heart, fetal, pool1	10046-101G1	1205.05	31.42	29.47	74.13	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	52.14	24.68	27.46	12.65	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	149.84	33.30	11.89	38.05	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	191.49	20.00	7.96	22.87	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	167.62	18.08	6.07	20.75	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	181.19	18.29	5.96	20.01	0.10
hepatoma cell line:Li-7	10484-107A7	95.09	10.57	5.78	4.34	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	66.83	32.56	10.05	18.69	0.00
hippocampus - adult, donor10196	10169-103B7	451.40	39.75	33.12	60.56	0.95
hippocampus, adult, donor10252	10153-102I9	329.83	38.98	35.72	44.09	0.00
hippocampus, adult, donor10258	10374-105G5	350.06	10.46	44.32	68.72	0.00
hippocampus, newborn, donor10223	10363-105F3	203.38	33.84	39.48	28.90	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	225.83	50.05	29.91	47.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	258.40	34.95	14.33	46.93	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	266.84	34.02	14.73	46.72	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	321.97	43.98	19.74	84.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	328.70	60.94	24.53	75.40	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	288.50	46.31	15.94	65.67	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	223.64	55.47	31.82	64.23	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	251.19	54.50	24.34	61.83	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	209.79	55.05	43.79	51.72	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	177.83	49.25	25.10	35.99	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	186.91	53.68	30.21	41.63	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	204.01	52.52	30.30	40.40	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	261.96	37.09	15.34	42.56	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	327.20	34.88	23.09	57.48	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	372.67	68.95	27.06	106.48	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	332.38	69.68	24.05	78.27	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	321.82	54.51	20.50	77.18	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	300.36	64.47	23.99	92.46	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	405.23	55.39	24.87	87.60	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	444.71	75.03	44.56	110.50	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	422.24	63.27	26.31	85.51	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	219.64	54.87	29.39	40.01	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	218.02	43.84	30.48	42.68	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	234.36	57.09	30.19	52.61	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	293.56	42.49	21.25	47.11	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	319.52	37.37	20.26	61.05	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	264.99	57.16	33.48	70.23	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	205.97	42.25	17.25	57.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	236.29	34.84	19.32	63.66	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	209.72	40.85	17.25	54.77	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	227.53	48.61	32.58	53.78	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	259.02	49.15	27.23	71.07	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	63.88	29.24	23.09	14.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	144.95	43.20	28.89	32.72	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	190.82	48.46	30.29	55.28	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	152.91	45.37	42.01	39.65	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	333.76	34.54	18.60	61.10	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	334.69	53.03	20.95	72.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	310.73	42.44	23.90	63.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	246.63	34.23	17.73	62.96	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	230.98	81.33	81.33	104.10	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	275.67	57.25	28.79	81.74	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	264.35	41.05	22.99	54.73	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	201.93	40.53	17.73	55.73	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	227.05	46.98	21.71	62.28	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	275.67	39.38	23.87	44.16	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	189.32	46.86	28.44	43.61	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	186.15	40.41	20.47	40.68	0.81
immature langerhans cells, donor1	11904-125F5	10.65	34.14	34.14	4.36	0.00
immature langerhans cells, donor2	11905-125F6	15.05	25.35	19.01	3.17	0.79
insula, adult, pool1	10039-101F3	272.45	31.51	27.16	31.51	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	17.23	15.93	7.48	3.90	0.00
kidney, adult, pool1	10017-101C8	116.15	29.64	27.74	13.22	0.10
kidney, fetal, pool1	10045-101F9	143.24	29.21	17.33	17.61	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	69.59	13.07	9.66	13.35	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	24.75	16.45	11.47	5.94	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	142.40	28.08	16.88	15.96	0.00
left atrium, adult, donor1	10079-102A7	694.68	46.86	49.04	85.00	0.00
left ventricle, adult, donor1	10078-102A6	1295.49	31.86	52.59	105.68	0.00
leiomyoblastoma cell line:G-402	10721-110A1	53.63	15.87	7.11	12.04	0.00
leiomyoma cell line:10964C	10569-108B2	24.07	16.17	12.57	5.03	0.36
leiomyoma cell line:15242A	10570-108B3	13.04	10.33	11.96	3.80	0.00
leiomyoma cell line:15425	10571-108B4	24.52	20.64	12.63	4.86	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	32.41	11.50	13.59	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	112.63	40.61	54.42	22.90	0.47
liposarcoma cell line:KMLS-1	10782-110G8	19.21	26.24	21.56	5.47	0.16
liposarcoma cell line:SW 872	10726-110A6	55.19	19.74	12.55	8.77	0.12
liver, adult, pool1	10018-101C9	88.16	14.26	12.48	7.94	0.00
liver, fetal, pool1	10086-102B5	147.69	14.11	8.47	20.70	0.00
locus coeruleus - adult, donor10196	10182-103D2	616.98	35.44	27.27	68.54	0.73
locus coeruleus, adult, donor10252	10165-103B3	388.66	30.82	25.28	38.57	0.37
locus coeruleus, adult, donor10258	10375-105G6	365.09	31.88	25.11	53.61	0.00
locus coeruleus, newborn, donor10223	10362-105F2	304.95	49.63	66.04	43.74	0.42
lung adenocarcinoma cell line:A549	10499-107C4	57.99	29.06	11.76	11.63	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	14.48	7.58	6.20	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.93	2.50	4.88	1.71	0.13
lung, adult, pool1	10019-101D1	89.54	25.87	22.21	11.10	0.12
lung, fetal, donor1	10068-101I5	369.03	79.63	63.08	45.67	0.57
lung, right lower lobe, adult, donor1	10075-102A3	88.89	66.44	56.82	27.49	0.00
lymph node, adult, donor1	10077-102A5	75.74	38.34	23.19	25.09	0.00
lymphangiectasia cell line:DS-1	10727-110A7	87.01	37.04	14.25	29.81	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	173.72	39.84	11.02	34.41	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	54.37	19.54	18.69	8.49	0.00
mature adipocyte, donor1	12231-129F8	41.74	11.54	9.32	12.88	0.00
mature adipocyte, donor2	12232-129F9	87.16	13.90	15.56	9.96	0.21
mature adipocyte, donor3	12233-129G1	75.86	14.93	13.28	9.25	0.24
mature adipocyte, donor4	12234-129G2	69.49	27.64	12.11	12.37	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	153.68	26.21	8.10	30.97	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	605.75	34.97	42.87	75.58	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	451.67	37.33	38.25	54.07	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	488.29	35.58	54.32	64.17	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	141.59	46.91	49.90	30.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	628.26	54.51	49.61	77.12	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	459.25	36.08	38.84	50.93	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	416.07	21.19	36.60	77.05	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	373.19	100.48	43.06	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	252.33	38.41	43.43	33.38	0.36
medulla oblongata - adult, donor10196	10174-103C3	428.97	27.91	35.69	56.46	0.65
medulla oblongata, adult, donor10252	10155-103A2	285.77	26.32	21.83	26.47	0.31
medulla oblongata, adult, pool1	10038-101F2	279.66	21.96	19.26	27.18	0.41
medulla oblongata, newborn, donor10223	10361-105F1	211.78	28.82	24.65	28.47	0.69
medulloblastoma cell line:D283 Med	10838-111E1	253.52	44.95	14.61	83.47	0.66
medulloblastoma cell line:ONS-76	10759-110E3	44.39	15.65	7.83	6.36	0.00
melanoma cell line:COLO 679	10514-107E1	58.50	35.07	40.39	16.10	0.00
melanoma cell line:G-361	10465-106H6	21.99	25.25	30.40	8.42	0.00
meningioma cell line:HKBMM	10691-109F7	31.12	30.39	23.70	9.41	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	131.29	47.58	29.96	21.15	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	158.13	31.37	20.48	18.92	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.19	28.08	25.32	4.76	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.63	20.72	18.72	4.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	42.65	19.05	29.40	12.01	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.15	16.44	10.68	4.92	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	21.95	15.21	17.14	6.16	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	32.62	18.74	20.13	3.47	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	84.79	31.75	31.92	16.13	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	31.74	14.95	15.87	6.21	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	17.38	16.98	19.10	3.58	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	23.90	19.72	24.44	4.46	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.59	16.08	16.79	4.69	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	78.39	24.04	39.52	20.09	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.10	8.99	12.59	2.63	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.39	17.80	17.80	7.33	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.78	19.40	16.13	4.29	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	24.44	8.63	11.50	12.22	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.66	13.76	10.45	3.72	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.36	7.30	11.40	4.79	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	21.40	15.10	2.94	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.23	16.44	14.05	3.74	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.73	13.22	10.94	6.30	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	50.44	9.94	11.78	12.89	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	28.62	7.15	11.73	5.15	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.31	29.89	30.73	3.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.07	15.07	19.64	4.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	21.49	14.32	23.79	5.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.28	16.23	16.49	4.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.49	14.48	16.64	2.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.89	13.18	18.12	4.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.97	16.58	18.62	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.04	11.79	20.04	4.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	16.22	19.00	4.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.42	17.59	22.50	6.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.83	15.62	14.72	3.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.86	14.90	18.03	5.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	15.40	5.87	12.47	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.75	11.41	14.77	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.19	11.46	17.60	3.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.47	15.46	15.89	3.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	13.67	8.20	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	15.49	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.72	15.26	16.24	3.25	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	18.91	11.64	7.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	17.06	19.19	6.40	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	6.54	11.45	13.08	3.27	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.77	14.38	12.44	5.44	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	18.89	8.39	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	7.95	7.95	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	14.30	19.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.86	12.45	12.45	2.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	12.18	13.40	2.44	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.13	17.10	13.93	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.69	16.90	25.87	3.10	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	10.75	19.34	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	15.97	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	10.33	34.44	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.00	17.93	21.60	5.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	18.27	19.86	19.86	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	21.81	19.45	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.61	19.64	18.70	7.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	24.06	25.40	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	8.28	9.46	3.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	10.27	10.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	8.95	8.26	4.13	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	40.08	11.38	10.39	6.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	26.92	15.70	12.34	7.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	11.45	14.63	7.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	49.57	10.88	7.25	8.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	50.15	6.54	17.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	43.08	13.94	7.60	7.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	110.45	20.63	14.57	38.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	117.49	31.63	18.08	36.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	108.73	18.12	21.42	22.24	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	56.35	23.81	23.22	10.91	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.37	22.07	16.55	4.22	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	10.19	17.32	5.09	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	43.33	11.61	18.57	10.06	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	126.39	39.92	17.95	21.03	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	26.18	13.44	11.82	3.24	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	4.27	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	22.81	15.10	12.95	7.09	0.00
mesothelioma cell line:Mero-25	10850-111F4	89.19	23.83	18.84	6.81	0.00
mesothelioma cell line:Mero-41	10851-111F5	14.91	17.60	10.02	3.67	0.00
mesothelioma cell line:Mero-48a	10852-111F6	19.26	17.71	14.84	5.09	0.22
mesothelioma cell line:Mero-82	10853-111F7	73.85	21.81	20.24	12.88	0.00
mesothelioma cell line:Mero-83	10854-111F8	25.19	13.79	13.96	8.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	11.37	7.58	4.55	2.27	0.00
mesothelioma cell line:Mero-95	10856-111G1	21.74	18.22	12.63	5.80	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	23.19	16.23	12.92	5.47	0.17
mesothelioma cell line:NCI-H226	10846-111E9	24.07	26.61	26.06	3.98	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	13.49	13.67	9.57	3.42	0.00
mesothelioma cell line:NCI-H28	10845-111E8	36.64	30.03	15.78	9.42	0.51
mesothelioma cell line:No36	10857-111G2	43.71	16.31	8.48	7.83	0.33
mesothelioma cell line:ONE58	10858-111G3	38.48	15.72	17.07	6.23	0.00
migratory langerhans cells, donor1	11901-125F2	18.81	28.02	9.79	7.48	0.58
migratory langerhans cells, donor2	11902-125F3	14.04	18.68	8.91	5.37	0.00
migratory langerhans cells, donor3	11903-125F4	18.67	24.77	18.85	8.44	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	177.60	20.24	15.02	11.75	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	88.17	25.22	12.72	19.50	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	87.08	23.50	13.36	16.82	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	29.88	31.02	18.65	6.09	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	59.50	34.56	16.26	11.09	0.37
myeloma cell line:PCM6	10474-106I6	57.72	35.78	21.35	10.08	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	37.54	19.78	12.17	8.12	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.01	21.97	20.79	7.06	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	148.31	24.62	10.92	11.48	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	139.58	27.65	11.62	16.62	0.07
nasal epithelial cells, donor2	12227-129F4	50.78	29.81	11.04	6.62	0.00
neuroblastoma cell line:CHP-134	10508-107D4	444.25	91.79	41.41	156.44	1.15
neuroblastoma cell line:NB-1	10539-107G8	150.04	49.39	31.99	25.63	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	91.31	5.69	2.95	9.07	0.42
neuroblastoma cell line:NH-12	10555-107I6	223.06	36.71	13.23	79.20	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	225.84	65.47	17.08	74.96	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	116.25	26.92	15.68	19.01	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	71.45	28.78	9.86	24.96	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	46.41	5.09	2.54	8.90	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	56.69	22.09	23.69	9.32	0.00
neutrophil PMN, donor1	12133-128D9	148.75	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	18.94	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	103.33	39.74	16.57	19.79	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	137.69	30.42	17.61	17.61	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	88.81	34.95	43.60	12.50	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.21	27.33	30.74	6.57	0.00
nucleus accumbens, adult, pool1	10037-101F1	265.56	29.15	25.68	31.78	0.19
occipital cortex - adult, donor10196	10172-103C1	692.29	45.33	41.21	117.44	0.00
occipital cortex, adult, donor10252	10163-103B1	438.77	42.13	31.13	53.40	0.54
occipital cortex, newborn, donor10223	10355-105E4	239.47	41.49	36.39	30.94	0.00
occipital lobe, adult, donor1	10076-102A4	399.63	56.68	86.85	62.19	0.26
occipital lobe, fetal, donor1	10073-102A1	1094.21	97.83	84.53	148.47	1.72
occipital pole, adult, pool1	10036-101E9	266.56	27.04	22.55	35.40	0.00
olfactory region, adult	10195-103E6	322.88	34.39	32.29	50.25	0.00
optic nerve, donor1	10277-104E7	294.15	16.01	36.02	32.02	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	55.36	20.28	13.67	8.20	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	85.32	15.66	2.61	12.36	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	38.44	14.22	10.84	7.79	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.33	15.59	9.36	5.78	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	22.05	23.81	25.58	3.53	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	43.91	16.82	14.02	7.47	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	39.44	30.54	28.42	7.63	0.00
ovary, adult, pool1	10020-101D2	157.32	17.82	14.85	20.00	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.21	17.23	11.55	7.52	0.00
pancreas, adult, donor1	10049-101G4	54.56	23.52	21.63	10.35	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.61	51.15	15.65	19.29	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	47.53	16.35	17.55	5.62	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	20.70	18.05	10.43	4.47	0.17
paracentral gyrus, adult, pool1	10035-101E8	290.67	26.91	21.78	35.24	0.09
parietal cortex, adult, donor10258	10373-105G4	318.56	17.62	34.50	32.30	0.00
parietal lobe - adult, donor10196	10171-103B9	512.56	21.63	31.04	55.49	0.00
parietal lobe, adult, donor10252	10157-103A4	537.29	33.63	29.93	57.58	0.29
parietal lobe, adult, pool1	10034-101E7	292.65	28.99	25.73	32.96	0.35
parietal lobe, fetal, donor1	10072-101I9	1147.31	126.08	47.52	181.36	1.94
parietal lobe, newborn, donor10223	10356-105E5	263.57	33.65	43.37	20.56	0.75
parotid gland, adult	10199-103F1	40.08	22.20	21.58	6.17	0.00
penis, adult	10200-103F2	90.23	26.32	16.11	11.28	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	227.03	15.62	4.46	29.01	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	61.92	20.69	8.45	8.45	0.00
pineal gland - adult, donor10196	10179-103C8	522.47	39.35	54.83	50.96	0.00
pineal gland, adult, donor10252	10160-103A7	702.36	85.28	99.49	93.57	0.59
pineal gland, adult, donor10258	10377-105G8	301.62	63.96	70.86	61.45	0.00
pituitary gland - adult, donor10196	10180-103C9	489.71	44.52	46.54	69.81	1.01
pituitary gland, adult, donor10252	10162-103A9	670.76	49.51	59.94	92.25	1.56
pituitary gland, adult, donor10258	10378-105G9	359.22	66.40	40.86	74.91	0.85
placenta, adult, pool1	10021-101D3	47.19	21.18	16.13	7.74	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	49.66	14.30	3.84	10.20	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	21.32	15.41	14.63	3.89	0.16
pons, adult, pool1	10033-101E6	319.31	16.70	16.61	36.32	0.43
postcentral gyrus, adult, pool1	10032-101E5	313.66	29.81	29.99	37.66	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	27.19	4.18	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	27.54	11.02	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	54.77	21.70	8.01	9.91	0.00
prostate cancer cell line:PC-3	10439-106E7	81.86	44.83	21.60	11.07	0.00
prostate, adult, pool1	10022-101D4	77.90	28.21	22.40	14.96	0.09
putamen, adult, donor10196	10176-103C5	408.86	32.58	30.45	34.23	0.47
putamen, adult, donor10252	10152-102I8	262.74	21.57	39.21	39.21	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	358.44	15.30	21.86	44.81	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	236.54	23.19	28.51	19.33	0.24
putamen, newborn, donor10223	10365-105F5	449.80	50.98	38.98	44.23	0.75
rectal cancer cell line:TT1TKB	10469-106I1	74.48	12.51	5.82	13.96	0.00
rectum, fetal, donor1	10067-101I4	189.17	66.77	44.51	54.25	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.48	15.05	8.06	2.54	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	28.99	9.53	4.97	0.00
retina, adult, pool1	10030-101E3	132.40	38.57	31.71	17.39	0.30
retinoblastoma cell line:Y79	10475-106I7	149.39	42.61	18.19	47.02	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	80.04	26.43	7.01	13.28	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	221.02	44.99	12.65	34.59	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	18.95	10.61	6.82	0.00
salivary acinar cells, donor1	11771-123I7	37.71	17.48	7.28	10.04	0.00
salivary acinar cells, donor2	11772-123I8	24.37	19.69	9.50	6.47	0.00
salivary acinar cells, donor3	11773-123I9	62.23	18.54	11.25	12.58	0.00
salivary gland, adult, pool1	10093-102C3	54.34	35.46	20.59	14.30	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.00	35.58	22.09	10.45	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	83.81	47.61	24.22	13.52	0.00
seminal vesicle, adult	10201-103F3	57.14	64.55	47.09	17.46	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	44.21	27.69	29.39	6.80	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	21.89	6.79	8.05	2.52	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	13.05	16.06	17.06	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	36.67	12.22	7.92	6.31	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	34.93	16.36	11.61	6.52	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.97	41.03	24.64	9.03	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	295.79	6.38	8.51	23.41	0.00
skeletal muscle, adult, pool1	10023-101D5	232.68	20.03	14.63	18.23	0.00
skeletal muscle, fetal, donor1	10066-101I3	168.84	32.16	11.06	34.17	0.00
skin, adult, donor1	10074-102A2	67.85	101.78	27.14	13.57	0.00
skin, fetal, donor1	10065-101I2	121.83	51.76	32.82	10.73	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	93.39	47.03	26.35	20.34	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	293.14	36.25	35.62	46.97	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	192.36	27.95	9.25	28.53	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	61.32	33.62	14.83	15.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	207.50	15.12	2.90	58.71	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	84.12	24.19	31.16	12.86	0.44
small intestine, adult, pool1	10024-101D6	75.37	42.52	34.64	10.75	0.36
small intestine, fetal, donor1	10064-101I1	131.45	82.06	26.78	40.54	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	42.57	21.54	18.98	6.67	0.00
smooth muscle, adult, pool1	10048-101G3	118.11	37.99	28.17	23.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	47.71	29.21	21.44	13.67	0.00
spinal cord - adult, donor10196	10181-103D1	590.03	57.12	40.60	64.69	0.00
spinal cord, adult, donor10252	10159-103A6	466.82	33.91	29.96	34.30	0.00
spinal cord, adult, donor10258	10369-105F9	363.89	14.53	50.50	48.43	0.00
spinal cord, fetal, donor1	10056-101H2	274.43	43.91	43.30	35.37	0.61
spinal cord, newborn, donor10223	10359-105E8	139.60	32.60	40.87	36.74	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	44.51	24.79	25.09	8.21	0.15
spleen, adult, pool1	10025-101D7	65.42	31.83	24.01	13.66	0.11
spleen, fetal, pool1	10044-101F8	110.28	27.25	21.61	13.19	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.70	19.67	6.11	4.97	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	82.41	31.52	13.48	12.91	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	218.06	33.55	15.73	15.03	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	102.03	30.10	28.15	25.41	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.04	22.62	18.12	5.74	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	66.93	22.03	11.01	15.25	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.31	16.50	11.85	5.50	0.00
stomach, fetal, donor1	10062-101H8	182.62	45.92	27.77	23.50	0.00
submaxillary gland, adult	10202-103F4	45.57	22.22	24.50	7.41	0.00
substantia nigra - adult, donor10196	10178-103C7	868.39	0.00	54.27	108.55	54.27
substantia nigra, adult, donor10252	10158-103A5	262.96	32.82	24.92	21.81	0.42
substantia nigra, adult, donor10258	10371-105G2	444.84	10.35	32.59	52.76	0.52
substantia nigra, newborn, donor10223	10358-105E7	273.44	40.27	30.38	24.02	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	73.59	34.62	20.18	11.69	0.23
temporal lobe, adult, pool1	10031-101E4	279.49	22.72	23.74	29.67	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	896.03	100.43	68.38	134.62	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	424.15	38.24	38.68	61.97	0.88
tenocyte, donor1	11763-123H8	21.64	16.06	13.61	5.59	0.00
tenocyte, donor2	11765-123I1	33.95	21.36	24.80	6.10	0.38
tenocyte, donor3	11768-123I4	30.77	14.83	18.16	5.56	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	198.34	37.39	13.60	31.44	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	237.54	41.77	21.27	38.38	0.46
teratocarcinoma cell line:PA-1	10807-111A6	167.07	38.59	13.95	35.49	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	99.91	26.53	20.06	20.95	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	139.17	32.90	12.48	32.52	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	69.69	39.37	20.18	21.81	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	158.62	34.52	9.12	42.34	0.00
testis, adult, pool1	10026-101D8	151.29	36.18	20.19	25.02	0.21
testis, adult, pool2	10096-102C6	390.19	48.27	22.55	57.29	0.90
thalamus - adult, donor10196	10168-103B6	546.47	34.22	39.74	71.76	0.00
thalamus, adult, donor10252	10154-103A1	249.43	29.22	28.13	23.44	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	457.27	4.62	24.63	104.69	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	262.68	29.15	31.79	48.75	0.33
thalamus, newborn, donor10223	10366-105F6	577.05	34.52	73.64	81.70	0.00
throat, adult	10209-103G2	86.64	22.72	31.46	8.49	0.25
throat, fetal, donor1	10061-101H7	112.74	50.28	31.69	20.11	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	70.95	23.85	7.35	22.06	0.00
thymus, adult, pool1	10027-101D9	67.30	37.88	18.39	17.10	0.00
thymus, fetal, pool1	10043-101F7	126.24	43.43	18.39	18.08	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.63	33.51	25.13	8.64	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	90.94	30.87	19.98	19.84	0.00
thyroid, adult, pool1	10028-101E1	103.76	33.59	29.39	17.54	0.00
thyroid, fetal, donor1	10060-101H6	116.54	61.96	39.81	18.72	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	110.87	46.19	33.88	3.08	3.08
tongue, adult	10203-103F5	97.68	18.37	18.14	9.07	0.00
tongue, fetal, donor1	10059-101H5	167.10	32.32	24.43	11.43	0.00
tonsil, adult, pool1	10047-101G2	66.72	31.05	17.93	13.62	0.20
trachea, adult, pool1	10029-101E2	49.16	22.33	20.78	9.49	0.08
trachea, fetal, donor1	10058-101H4	127.33	44.62	27.31	22.70	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.93	28.34	24.09	11.34	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	29.08	18.24	8.31	4.56	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	204.79	67.53	26.48	49.36	0.78
tridermal teratoma cell line:HGRT	10694-109G1	55.17	17.12	7.61	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	42.66	39.45	28.61	13.80	0.08
umbilical cord, fetal, donor1	10057-101H3	312.98	39.64	16.69	47.99	0.00
uterus, adult, pool1	10100-102D1	136.33	45.05	34.13	26.11	0.34
uterus, fetal, donor1	10055-101H1	89.59	48.63	37.37	28.67	0.00
vagina, adult	10204-103F6	129.24	20.68	16.80	19.39	0.00
vein, adult	10191-103E2	51.73	31.35	23.67	14.25	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	36.32	33.11	10.41	10.68	0.00